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Despite evidence showing that anticholinergic drugs
are of clinical relevance in Parkinson’s disease (PD),
the causal role of striatal cholinergic interneurons
(CINs) in PD pathophysiology remains elusive.
Here, we show that optogenetic inhibition of CINs
alleviates motor deficits in PD mouse models,
providing direct demonstration for their implication
in parkinsonian motor dysfunctions. As neural corre-
lates, CIN inhibition in parkinsonian mice differen-
tially impacts the excitability of striatal D1 and D2
medium spiny neurons, normalizes pathological
bursting activity in the main basal ganglia output
structure, and increases the functional weight of
the direct striatonigral pathway in cortical informa-
tion processing. By contrast, CIN inhibition in non-
lesioned mice does not affect locomotor activity,
equally modulates medium spiny neuron excitability,
and does notmodify spontaneous or cortically driven
activity in the basal ganglia output, suggesting that
the role of these interneurons in motor function is
highly dependent on dopamine tone.
INTRODUCTION
Parkinson’s disease (PD) is a debilitating neurodegenerative
movement disorder resulting from the loss of nigral dopami-
nergic (DA) neurons that project massively to the striatum, the
main basal ganglia input structure. The hypokinetic parkinsonian
syndrome is thought to be the consequence of opposite
changes in the activity of the two populations of GABAergic stria-
tal projection neurons, also called medium spiny neurons
(MSNs), which control the basal ganglia output nuclei, mainly
the substantia nigra pars reticulata (SNr) in rodent. Dopamine
D1 receptor-expressing MSNs (D1 or direct MSNs), giving riseCto a monosynaptic inhibitory projection (direct pathway) onto
SNr, become hypoactive, whereas dopamine D2 receptor-ex-
pressing MSNs (D2 or indirect MSNs), at the origin of a polysyn-
aptic projection with excitatory influence onto SNr (indirect
pathway), become hyperactive (Albin et al., 1989; Mallet et al.,
2006). This imbalance leads to pathological activation of SNr, re-
inforcing its inhibitory tone onto the thalamocortical circuit and,
hence, on motor cortical outflow. The pathological changes in
the activity of the two striatal pathways, whose functional rela-
tionship with movement control is still debated (Calabresi
et al., 2014; Cui et al., 2013), may involve profound reorganiza-
tions within the striatal circuitry.
Striatal cholinergic interneurons (CINs), which correspond to
the tonically active neurons recorded in vivo, constitute 1%–
3% of all striatal neurons. Despite being few in numbers, they
are the main source of acetylcholine (ACh) within the striatum,
and their dense terminal fields are primarily directed to MSNs
(Phelps et al., 1985). The improvement of parkinsonian tremor
by both DA agonists and anticholinergic drugs led to the DA-
ACh balance hypothesis, where DA and ACh are believed to
play opposite roles in the striatum (Barbeau, 1962). This clinical
observation particularly underlines the functional impact of ACh
as DA levels fall. There is indeed compelling evidence showing
that DA depletion triggers complex alterations in striatal cholin-
ergic signaling and activity (Aosaki et al., 1994; Ding et al.,
2006), leading, among other things, to morphofunctional alter-
ations of striatal output neurons (Pisani et al., 2007; Shen et al.,
2007). However, whether and how this cholinergic-dependent
disruption of striatal properties contributes to motor symptoms
in PDand affects basal ganglia circuitry remain an openquestion.
The diversity of cholinergic receptors expressed in the stria-
tum, located both at the presynaptic and postsynaptic levels
(Goldberg et al., 2012), suggests that CINs exert complex and
powerful influence on striatal functioning and, hence, on basal
ganglia outflow. An additional level of complexity in understand-
ing cholinergic regulation of striatal function comes from recent
studies showing the following: (1) CINs co-release glutamate
able to evoke fast glutamatergic responses in MSNs (Higleyell Reports 13, 657–666, October 27, 2015 ª2015 The Authors 657
Figure 1. Photoinhibition of CINs rReduces Haloperidol-Induced Catalepsy and Relieves Parkinsonian-like Motor Deficits
(A) Experimental design. Mice received haloperidol (0.25 mg/kg) and the latency to step down the bar was measured 20min later, then every 10min, with a 120-s
cutoff. Light was turned on (blue light: 10 Hz, 25-ms pulse width; yellow light: continuous illumination) for 3 min when placing the mice on the bar and was turned
off afterward for 7 min, until next measure.
(B) Yellow light reduced haloperidol-induced catalepsy in eNpHR-RFP mice versus RFP mice (*p < 0.05, **p < 0.01, U-Mann-Whitney after significant Kruskal-
Wallis test), whereas blue light illumination in ChR2-mCherry mice had no effect versus mCherry mice (p = 0.3).
(legend continued on next page)
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et al., 2011), (2) CIN activation can drive GABA release from
dopaminergic terminals (Nelson et al., 2014; Tritsch et al.,
2014) and neuroptide Y-expressing interneurons (English et al.,
2011), and (3) their synchronous activation triggers striatal DA
release (Threlfell et al., 2012). While we do not know yet how
these different actions are coordinated in vivo, these results sug-
gest that DA/ACh interactions are more complex than the tradi-
tional antagonistic model would predict. Therefore, the contribu-
tion of CINs to basal ganglia function cannot be fully understood
unless an approach mimicking the diversity of their actions is
used. Optogenetics that allows precise control of circuit func-
tion, was, for example, used successfully to demonstrate the
role of CINs in the nucleus accumbens during cocaine condition-
ing (Witten et al., 2010).
Here, using a combination of optogenetic, behavioral, and
electrophysiological approaches, we demonstrate a major role
of CINs in PD pathophysiology. We show that selective inhibition
of CINs alleviates motor deficits and corrects dysfunctions at the
main input and output stages of the basal ganglia network in PD
mouse models, with a preferential action on the direct striatonig-
ral pathway.
RESULTS
Inhibition of Striatal Cholinergic Interneurons Reduces
Parkinsonian-like Motor Deficits
We expressed ChR2-mCherry or eNpHR-RFP in choline acetyl-
transferase (ChAT)-expressing neurons by injecting a Cre-
dependent adeno-associated virus (AAV) carrying the opsins or
their reporter genes into the dorsal striatum of ChATcre/cre mice
(subsequently referred to as ChR2-mCherry and eNpHR-RFP
mice). Quantifying the proportion of neurons expressing opsins
that were also ChAT positive and vice versa demonstrated the
specificity and efficiency of the targeting strategy (Figure S1).
Recordings of optogenetically identified CINs in striatal slices
and anesthetized mice showed that opsins were functional
(Figure S2).
CIN photoinhibition or photoactivation had no significant ef-
fect on locomotor activity of non-lesioned RFP, eNpHR-RFP,
mCherry, and ChR2-mCherry mice in an open field (Figure S3A).
To determine whether CINs affect parkinsonian akinesia, the
effects of CIN modulation were examined in the haloperidol-
induced catalepsy model (Figure 1A). The eNpHR-RFP haloper-
idol-treated mice removed their forepaws from the bar signifi-
cantly faster under yellow illumination than did the RFP-treated
mice (Figure 1B). Consistently, yellow light restored head move-(C) Light partially restored headmovements in eNpHR-RFPmice (ON versus OFF p
way ANOVA), but not in ChR2-mCherry mice or in control RFP and mCherry mic
(D) In the cylinder test, 6-OHDA mice showed marked forelimb asymmetry compa
test after significant ANOVA). (Left) This asymmetry was significantly improved by
Light did not affect asymmetry in RFP control mice (n = 7–8 per group). (Right) The
(**p < 0.01, Fisher’s LSD test after significant ANOVA) was not affected by blue
mCherry (ON versus OFF: ns, Student’s t test) mice (n = 7–8 per group).
(E) (Left) Ipsilateral turn bias induced by 6-OHDA lesion in the cross maze (6-OHD
photoinhibition in eNpHR-RFPmice (ON versus OFF: #p < 0.05, paired Student’s t
not affect the ipsilateral turn bias induced by 6-OHDA lesion (6-OHDA versus non
mice (ON versus OFF: ns, Student’s t test, n = 12 per group). In (D) and (E), contin
10 Hz for blue light. Circle under the cross maze symbolizes a mouse with the 6
Cments in a light-locked manner in haloperidol-injected eNpHR-
RFP mice, demonstrating a robust anti-akinetic action of CIN
inhibition (Figure 1C). In contrast, ChR2-mCherry mice under
blue illumination exhibited a long-lasting cataleptic state, similar
to mCherry mice (Figures 1B and 1C).
We next tested whether CIN inhibition could alleviate motor
dysfunction in the 6-hydroxydopamine (6-OHDA) lesional model
of PD. Unilateral 6-OHDA injection into the substantia nigra pars
compacta (SNc) resulted in a near-total loss of DA cells after
2 weeks. In the cylinder test (Figure 1D), RFP and mCherry
non-lesioned mice used their two forepaws indifferently during
exploratory rearing (asymmetry score close to zero). The
6-OHDA lesions produced a significant shift toward ipsilateral
forepaw use due to contralateral forelimb akinesia. Photoinhibi-
tion of CINs ipsilateral to the lesioned side in eNpHR-RFP mice
induced a significant reduction in the asymmetry score. In
contrast, CIN photoactivation in ChR2-mCherry 6-OHDA mice
did not affect asymmetry (Figure 1D). In the cross maze test (Fig-
ure 1E), the 6-OHDA-induced bias toward ipsilateral turns, which
reflects sensorimotor neglect, was significantly reduced by CIN
inhibition in eNpHR-RFPmice, while CIN activation had no effect
in ChR2-mCherry mice. The non-selective muscarinic receptor
antagonist scopolamine (1 mg/kg) also reduced the asymmetry
in the cylinder and cross maze tests in 6-OHDA mice (Figures
S3B and S3C). Finally, we examined the effect of CIN photoinhi-
bition on L-DOPA-induced dyskinesia, amain side effect of long-
term DA treatment. CIN inhibition in eNpHR-RFP mice failed to
affect the severity of dyskinesia once expressed (Figure S4).
Taken together, these data show that CIN inhibition has no effect
on spontaneous locomotion and L-DOPA-induced dyskinesia in
our lesion and treatment conditions, but significantly alleviates
parkinsonian-like motor deficits.
Inhibition of Striatal CINs Regulates the Basal Ganglia
Output Structure in Parkinsonian Condition Only
A leading hypothesis on the origin of motor dysfunction in PD is
that DA loss induces abnormal bursting activity in basal ganglia
output nuclei, leading to pathological inhibitory tone onto the
thalamocortical circuit that disrupts motor planning and execu-
tion. We tested whether striatal CIN inhibition modifies the activ-
ity of SNr neurons recorded in vivo in anesthetized transgenic
eNpHR mice. CIN photoinhibition in non-lesioned animals did
not affect spontaneous activity of SNr neurons (Table S1). The
6-OHDA mice showed altered burst firing, with significant in-
creases in burst duration and number of spikes per burst (Fig-
ure 2A). CIN photoinhibition normalized these changes, withoutreceding light: *p < 0.05, **p < 0.01, paired Student’s t test after significant two-
e (n = 10–13 per group).
red to non-lesioned mice (**p < 0.01, Fisher’s least significant difference [LSD]
yellow light in eNpHR-RFP mice (ON versus OFF: #p < 0.05, Student’s t test).
significant forelimb asymmetrymeasured in 6-OHDA versus non-lesionedmice
light illumination in ChR2-mCherry (ON versus OFF: ns, Student’s t test) and
A versus non-lesioned: **p < 0.01, one-way ANOVA) was partially corrected by
test), but not in RFP control mice (n = 14 per group). (Right) Photoactivation did
-lesioned: **p < 0.01, one-way ANOVA) in ChR2-mCherry mice nor in mCherry
uous illumination was for 5 min with yellow light and 25-ms pulse width was at
-OHDA-injected side in red. Errors bars, SEM.
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Figure 2. Photoinhibition of CINs Normal-
izes SNr Burst Firing and Strengthens the
Inhibitory Influence of the Striatonigral
Direct Pathway in 6-OHDA Mice
(A) Detection of bursts according to Poisson
Surprise analysis in a spontaneously firing SNr
neuron recorded in 6-OHDA transgenic eNpHR
mice. The histograms show that the 6-OHDA
induced increases in burst duration and number of
spikes per burst (6-OHDA versus non-lesioned:
*p < 0.05, **p < 0.01, Student’s t test) were
normalized by CIN photoinhibition (light was
delivered for 1 min; 6-OHDA ON versus OFF: #p <
0.05, ##p < 0.01, Holm-Sidak test after significant
one-way ANOVA). Non-lesioned mice, n = 18 cells
from six mice; 6-OHDA mice, n = 13 cells from six
mice.
(B) Schematic representation shows pathways
activated by cortical stimulation that project to SNr
neurons. Cx, cortex; Str, striatum; GPe, external
globus pallidus; STN, subthalamic nucleus.
(C) Raster plot and peristimulus time histogram
(PSTH) show the typical triphasic response
evoked by motor cortex stimulation in one SNr
neuron recorded from a 6-OHDA transgenic
eNpHR mouse.
(D and E) Population PSTHs of the cortically
evoked responses recorded in SNr neurons in
non-lesioned (D, n = 17 cells from six mice) and
6-OHDA (E, n = 7 cells from five mice) mice.
The same neuron was recorded before (pre,
gray line) and during (light, orange line) CIN
photoinhibition. Light was delivered for 1 s at
the beginning of each trial. PSTHs are aligned
on the beginning of the inhibitory component
(red lines) and the light-shaded colors represent
SEM. CIN photoinhibition induced a significant increase of the inhibitory component duration only in 6-OHDA mice, as illustrated by the box plots
(insets) (**p < 0.01, Holm-Sidak test after significant one-way RM ANOVA). Errors bars, SEM.modifying the parameters unaltered by the lesion (firing fre-
quency and burst recurrence) (Table S1).
Next, to examine whether CINs influence the processing of
cortical information through the trans-striatal pathways, we
recorded the responses of individual SNr neurons to cortical
stimulation (Figures 2B and 2C). As previously reported, such
stimulation triggers a complex response composed, in most
cases, of an early excitation followed by an inhibition and a late
excitation, which has been attributed to the respective activation
of the hyperdirect corticosubthalamic, the direct and indirect
striatonigral pathways (Maurice et al., 1999; Ryan and Sanders,
1994; Sano et al., 2013; Tachibana et al., 2008). Because the
characteristics of the evoked responses greatly vary among cells
depending on the stimulation (e.g., location and number of stim-
ulated fibers) but remain stable in a given cell over time, compar-
isons were made for a same cell under successive light condi-
tions and not between cells from 6-OHDA versus non-lesioned
mice. CIN photoinhibition had no effect on cortical information
transfer in non-lesioned mice, whereas, in 6-OHDA mice, it
increased the duration of the inhibitory component of the tripha-
sic response without significantly affecting the excitatory com-
ponents (Figures 2D and 2E; Table S2). Since parkinsonian aki-
nesia is classically associated with overactive indirect pathway660 Cell Reports 13, 657–666, October 27, 2015 ª2015 The Authorsand hypoactive direct pathway, our results suggest that CIN in-
hibition might partially restore balance in striatal outputs by
increasing the functional impact of the direct pathway. In
contrast, CIN photoinhibition had no effect on SNr spontaneous
activity and cortical information transfer in non-lesioned trans-
genic eNpHR mice.
Dopamine Depletion Affects the Intrinsic Excitability
of D1 MSNs
We first determined whether CINs themselves were affected by
6-OHDA lesion, as there is no consensus on whether CIN activity
or striatal ACh release increases in PD models. Optogenetically
identified CINs recorded either in slices or in anesthetized mice
exhibited similar firing frequency in non-lesioned and 6-OHDA
conditions (Figure 3), showing that they are not hyperactive in
our experimental conditions. However, CINs were more excit-
able in slices from 6-OHDA mice, as illustrated by a lower rheo-
base current (non-lesioned: 137.7 ± 16.7 pA, n = 17; 6-OHDA:
87.1 ± 16.5 pA, n = 17; p < 0.05, Mann-Whitney test).
We then tested whether CIN modulation of striatal functions
could be altered in PD state, by examining its impact on iden-
tified D1 and D2 MSNs that form the direct and indirect striatal
projection systems, 2–3 weeks after 6-OHDA lesion. The
Figure 3. Impact of 6-OHDA Lesion on CIN Electrophysiological
Properties
(A) Spontaneous activity from a CIN recorded in cell-attached configuration.
Histograms show the mean firing rate and coefficients of variation (CV = firing
rate SD/firing rate mean) in non-lesioned (n = 12 cells) and 6-OHDA (n =
20 cells) transgenic eNpHR mice (ns, Mann-Whitney test).
(B) Action potential characteristics of CINs recorded in non-lesioned (n =
13 cells) and 6-OHDA (n = 22 cells) mice. No significant differences were
observed between the two groups (ns, Student’s t test).
(C) Spontaneous activity and optogenetic identification of a CIN recorded
in vivo. Histograms show themean frequency rate and CVs (firing rate SD/firing
rate mean) in non-lesioned (n = 8 cells) and 6-OHDA (n = 7 cells) transgenic
eNpHR mice (ns, Mann-Whitney test). Errors bars, SEM.
Cresting membrane potentials of D1 and D2 MSNs were similar
in non-lesioned and 6-OHDA mice (data not shown). However,
in non-lesioned mice, D2 MSNs were more excitable than D1
MSNs, in agreement with previous reports (Gertler et al.,
2008; Kreitzer and Malenka, 2007; Figure 4A). After DA deple-
tion, D2 MSN excitability was not changed, while that of D1
MSNs greatly increased. D1 MSNs fired at higher frequency
at each depolarizing current step, and the rheobase current
was significantly lower in 6-OHDA versus non-lesioned mice
(Figure 4). These results show that DA depletion reduces the di-
chotomy between D1 and D2 MSN excitability by increasing D1
MSN excitability.
Striatal CINs Differentially Modulate the Excitability
of D1 and D2 MSNs in Parkinsonian Condition
Changes in intrinsicmembrane excitability can occur either inde-
pendently or in concert with changes in synaptic inputs. As
cortical inputs strongly drive MSN activity and are modulated
by presynaptic muscarinic receptors (Herna´ndez-Echeagaray
et al., 1998; Malenka and Kocsis, 1988; Pakhotin and Bracci,
2007), we investigated whether CIN inhibition affects cortico-
striatal transmission. Recordings were made 2–3 weeks after
6-OHDA lesion in transgenic eNpHR/D1 mice expressing both
eNpHR in CINs and the fluorescent reporter tdTomato in DA
D1 receptor-containing neurons (Figure S5A). In non-lesioned
mice, excitatory postsynaptic currents (EPSCs) were not signifi-
cantly altered by CIN inhibition, both in D1 and D2 MSNs (D1
MSNs, light versus pre-light: 325.99 ± 57.92 pA versus
311.16 ± 53.47 pA, not significant [ns], paired Student’s t test,
n = 14 cells; D2 MSNs, light versus pre-light: 214.98 ±
30.07 pA versus 214.59 ± 26.44 pA, ns, paired Student’s t test,
n = 11 cells) (Figure S5B). In contrast, CIN inhibition in 6-OHDA
mice significantly potentiated EPSCs in both D1 and D2 MSNs
(D1 MSNs, light versus pre-light: 262.22 ± 24.93 pA versus
240.76 ± 23.84 pA, p < 0.05, Wilcoxon test, n = 15 cells; D2
MSNs, light versus pre-light: 231.06 ± 34.00 pA versus
198.06 ± 24.07 pA, p < 0.05, Wilcoxon test, n = 9 cells) (Fig-
ure S5B). This potentiation was blocked by scopolamine
(10 mM) (data pooled for D1 and D2 MSNs: light versus pre-light:
181.24 ± 35.92 pA versus 178.31 ± 33.35 pA, ns, paired Stu-
dent’s t test, n = 8 cells, data not shown). These results show
that CIN inhibition potentiates corticostriatal transmission onto
both D1 and D2MSNs in parkinsonian condition. Therefore, cor-
ticostriatal transmission is unlikely to contribute to a differential
impact of CIN inhibition on D1 and D2 MSNs.
In the healthy striatum, cholinergic modulation facilitates the
firing of MSNs through M1 receptors (Galarraga et al., 1999;
Goldberg et al., 2012; Pisani et al., 2007). What happens after
chronic DA depletion is still unclear. We therefore examined
whether and how CIN photoinhibition impacts MSN excitability
in non-lesioned and 6-OHDAmice. D1 and D2MSNs fired signif-
icantly less action potential during light illumination in both non-
lesioned and 6-OHDA mice (Figures 5A and 5B). However, while
the magnitude of firing inhibition was similar in D2 and D1 MSNs
in non-lesioned mice, firing inhibition was weaker in D2 MSNs
compared to D1 MSNs in 6-OHDA mice (Figure 5C). This result
shows that D2 MSNs are less sensitive to CIN inhibition than
D1 MSNs after DA depletion.ell Reports 13, 657–666, October 27, 2015 ª2015 The Authors 661
Figure 4. Impact of 6-OHDA Lesion on D1 and D2 MSN Excitability
(A) Current-clamp recordings showing the responses of D1 and D2 MSNs to
depolarizing current pulses in non-lesioned (+450 pA) and 6-OHDA (+400 pA)
mice. Summary graph illustrates the number of action potentials as a function
of injected current in D1MSNs (non-lesioned mice, n = 14 cells; 6-OHDAmice,
n = 23 cells) and D2 MSNs (non-lesioned mice, n = 13 cells; 6-OHDA mice, n =
13 cells).
(B) Bars graph shows the mean rheobase current in D1 MSNs (non-lesioned
mice, n = 14 cells; 6-OHDA mice, n = 23 cells) and D2 MSNs (non-lesioned
mice, n = 13 cells; 6-OHDA mice, n = 13 cells) (**p < 0.01, ***p < 0.001, Holm-
Sidak test after significant one-way ANOVA). Errors bars, SEM.DISCUSSION
Although ACh is undeniably a critical player in striatal func-
tioning, the role of CINs in PD pathophysiology has remained un-662 Cell Reports 13, 657–666, October 27, 2015 ª2015 The Authorssolved. We tackled this issue by combining optogenetics with
in vitro and in vivo electrophysiology and behavioral analyses.
We first showed that selective inhibition of CINs in the dorsal
striatum reduces parkinsonian motor dysfunction in pharmaco-
logical and lesional PD models, attesting to their causal involve-
ment in PD symptomatology. This provides a functional support
for the long-standing hypothesis that poses PD as a striatal
cholinergic disorder. Second, we identified several physiological
parameters affected by CIN inhibition in the parkinsonian condi-
tion at both the input (striatum) and output (SNr) levels of the
basal ganglia network. In addition, we found that CIN inhibition
does not significantly impact basic motor function nor the
spontaneous and cortically driven activity of SNr neurons in
non-lesioned mice. This lack of effect in SNr is consistent with
previous results from selective CIN ablation (Sano et al., 2013).
Also, CIN inhibition does not modify the severity of dyskinesia
in 6-OHDAmice. Altogether, these data suggest that CIN actions
are highly dependent on DA tone.
CIN inhibition in vivo efficiently alleviates parkinsonian deficits
measured after 6-OHDA lesions and neuroleptic-induced cata-
lepsy, two different models widely used to assess motor symp-
toms reminiscent of parkinsonian akinesia. As neural correlates
of PD symptoms’ improvement by CIN inhibition, our in vivo re-
cordings showed that it normalized the 6-OHDA-induced
changes in SNr burst firing. Over the last few years, an abundant
literature has clearly reported that parkinsonism is associated
with increased bursting activity in the basal ganglia, including
SNr (Lobb, 2014; Rivlin-Etzion et al., 2006; Wichmann et al.,
1999). Even though themechanisms leading to this abnormal ac-
tivity are still elusive, its normalization by efficient antiparkinso-
nian treatments, such as dopatherapy or subthalamic nucleus
deep brain stimulation (Brown, 2003; Degos et al., 2005; Eusebio
et al., 2011), suggests that such change may contribute impor-
tantly to the development of the behavioral manifestations of
the disease. Thus, it is likely that the decrease in burst activity
of SNr neurons elicited by CIN inhibition contributes to the
improvement of parkinsonian symptoms that we observed in
6-OHDAmice. Future studies will be required to understand fully
how CINs influence SNr burst firing in PD.
The second effect of CIN inhibition revealed by our in vivo re-
cordings in 6-OHDA mice was an increase in the inhibitory
component of the cortically evoked triphasic response in SNr
neurons, suggesting that CIN silencing strengthens the inhibitory
influence of the direct striatonigral pathway in parkinsonian con-
dition. Although the relationship between the activity of the direct
and indirect pathways and movement generation is still under
debate, it has been demonstrated that specific activation of D1
MSNs by optogenetics efficiently relieves parkinsonian deficits
(Kravitz et al., 2010). In this context, it is likely that the increased
duration of the cortically evoked inhibition induced by CIN inhibi-
tion contributes importantly to the improvement of parkinsonian-
like motor symptoms induced by DA depletion.
What are the striatal targets modulated by CINs that could
mediate their preponderant action on basal ganglia function in
PD state?We showed that CIN inhibition in 6-OHDAmice poten-
tiates corticostriatal transmission onto both types of MSNs.
However, our recordings in the SNr of 6-OHDA mice clearly
showed that CIN inhibition increases the cortically evoked
Figure 5. Photoinhibition of CINs Differentially Decreases D1 and D2 MSN Excitability in 6-OHDA Mice
(A and B) The graphs illustrate the decreased excitability of MSNs during light illumination versus pre and post conditions in non-lesioned (A, top; D1 MSNs:
F(2, 572) = 55.26, p < 0.0001, n = 12; B, top; D2 MSNs: F(2, 524) = 37.97, p < 0.0001, n = 11, linear regression analysis) and 6-OHDA (A, bottom; D1 MSNs:
F(2, 953) = 209.72, p < 0.0001, n = 20; B, bottom; D2MSNs: F(2, 524) = 17.09, p < 0.0001, n = 11, linear regression analysis) mice. R is theminimal current intensity
to trigger a spike in pre-light condition. From R, current intensity increased by +10-pA increment.
(C) (Top) Representative traces showing the responses to 500-ms depolarizing current steps (R+80 for D1MSNnon-les., D2MSNnon-les., andD2MSN 6-OHDA)
and R+110 (D1 MSN 6-OHDA). Light was delivered 200 ms before and continued 200 ms after the 500-ms depolarizing current step. (Bottom) The graphs show
the difference in the number of action potentials evoked in pre versus light conditions in D1MSNs (left; non-les., n = 12; 6-OHDA, n = 20) and D2MSNs (right; non-
les., n = 11; 6-OHDA, n = 11). There is a significant effect of current intensity in D1 MSNs (F[15,450] = 3.67, p < 0.005) and D2 MSNs (F[15,300] = 2.02, p < 0.01).
FromR+80 pA, D2MSNs in 6-OHDAmice are less inhibited during light illumination, as shown by a significant interaction between lesion3 current intensity for D2
MSNs (F[15,300] = 2.39, p < 0.05), but not for D1 MSNs. Errors bars, SEM.
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inhibition linked to the activation of the direct (D1) pathway, but
not the late excitation linked to the activation of the indirect
(D2) pathway. The high degree of convergence of the direct
pathway at the level of the SNr (48 striatal neurons converge
into one SNr cell; Smith et al., 1998) may explain how a modest
increase in corticostriatal transmission onto D1 MSNs impacts
the cortically evoked inhibition in the SNr. In contrast, complex
information processing at each stage of the polysynaptic indirect
pathway might minimize the outcome of EPSC potentiation on
D2 MSNs.
Another interesting result of our study is that DA depletion
tends to erase the dichotomy in MSN excitability by inducing a
specific increase in D1 MSN excitability. A recent study also re-
ported increased D1 MSN excitability after DA lesion, but asso-
ciated with a slight decrease in D2 MSN excitability (Fieblinger
et al., 2014), whereas we failed to detect any change for D2
MSNs. This apparent discrepancy might be due to different
lesion models or post-lesion delay, since opposite changes in
D2 MSN excitability have been described after acute or chronic
DA depletion (Day et al., 2006; Fieblinger et al., 2014; Shen et al.,
2007). Elevated excitability in D1MSNsmight be considered as a
homeostatic response counteracting the decreased activity trig-
gered by the loss of dopaminergic excitatory drive on these neu-
rons. However, if we assume that the dichotomybetween D1 and
D2 MSN excitability is a fundamental process for normal striatal
function, making both MSNs more alike after DA depletion might
be more harmful than beneficial. In favor of this hypothesis, we
showed that CIN inhibition decreases the excitability more in
D1 than in D2 MSNs after DA depletion, whereas it has similar
impact on the two populations in control condition. Thus,
restoring the dichotomy between D1 and D2 MSN excitability
might be one component of the anti-parkinsonian effect of CIN
inhibition. What happens following DA depletion to explain the
reduced sensitivity of D2 MSNs to CIN inhibition remains an
open and challenging question. It will be also interesting to inves-
tigate whether the cholinergic projection from the brainstem to
the striatum (Dautan et al., 2014) cooperates with CINs to modu-
late striatal output.
Our results show that CINs are critical players in the host of
cellular and synaptic changes induced inMSNs by DA depletion.
Without excluding indirect pathway contributions, our findings
point to CIN control of the direct striatonigral pathway as a
critical component involved in the control of striatal output and
motor dysfunction in PD state. These results should stimulate
the development of therapeutic strategies targeting striatal CIN
activity in PD.
EXPERIMENTAL PROCEDURES
Mice
All procedures were approved by the French National Ethical Committee (45-
29102012) and were in accordance with the recommendations of the Euro-
pean Commission (2010/63/EU) for care and use of laboratory animals. See
the Supplemental Experimental Procedures for a detailed description of the
mice used.
Stereotaxic Surgery
All coordinates were adapted from themouse stereotaxic atlas by Paxinos and
Franklin (2001) with bregma and dura as references. See the Supplemental
Experimental Procedures for details.664 Cell Reports 13, 657–666, October 27, 2015 ª2015 The AuthorsIn Vitro Electrophysiology
Patch-clamp recordings on brain slices and data analysis were performed as
described in the Supplemental Experimental Procedures. Excitation of opsins
was achieved with a light-emitting diode source (Spectra light engine, Lumen-
cor) connected to a 3-mm liquid core fiber. Statistical analyses were per-
formed using paired or unpaired Student’s t test. Nonparametric tests
(Mann-Whitney test for unpaired data or Wilcoxon test for paired data) were
used if the normality or equal variance test failed. For multiple group compar-
isons, one- or two-way ANOVA was used. We applied the log2 transformation
to make the data normal if necessary. Linear regression analysis was used to
compare the effect of CIN inhibition on MSN excitability. A significance of p <
0.05 was required for rejection of the null hypothesis.
Behavioral Testing
All behavioral analyses were conducted on littermates that entered the study
at around 3–5 months of age. See the Supplemental Experimental Proce-
dures for a detailed description of the behavioral tests. For open field,
data were analyzed using two-way ANOVA followed by paired Student’s t
test, when appropriate. For haloperidol-induced catalepsy, median latencies
(±semi-quartile) were compared among groups over time using the nonpara-
metric Kruskal-Wallis test, followed by U-Mann-Whitney for pairwise com-
parisons at each time. Head movements were summed for the 3-min ON
periods and compared to those measured 3-min OFF periods, using a
two-way ANOVA. For cylinder and cross maze tests, data were analyzed us-
ing one-way ANOVA, followed by Student’s t test. For L-DOPA-induced
dyskinesia, data were analyzed by two-way repeated-measures (RM)
ANOVA with opsins (eNpHR-RFP versus RFP) as between factor and time
as within factor.
In Vivo Recordings in Anesthetized Mice
Extracellular recordings in the striatum and the SNr were performed as
described in the Supplemental Experimental Procedures. The patterns of
cortically evoked discharges in the same SNr neuron were analyzed before,
during, and after CIN photoinhibition in the striatum. Results are given as
means ± SEM of the individual responses per condition. Spontaneous activity
in the three conditions was compared using one-way ANOVA followed by
comparison versus pre-light condition (Holm-Sidak method). Cortically
evoked responses of the same SNr neurons in the three light conditions
were compared using one-way RM ANOVA, followed by comparison versus
pre-light condition (Holm-Sidak method).
Histology and Immunohistochemistry
For primary antibody exposure, brain sections were incubated overnight at
4C in rabbit anti-RFP (1/1,000, tebu-bio, 600-401-379) and goat anti-ChAT
(1/100, Millipore, AB144P) for colocalization experiments and in mouse anti-
tyrosine hydroxylase (1/1,000, Millipore, MAB318) to control DA lesion. Sec-
tions were then incubated, respectively, in Alexa Fluor 555 donkey anti-rabbit
(1/500, Invitrogen, A31572), Alexa Fluor 488 donkey anti-goat (1/500, Invitro-
gen, A11055), and Alexa Fluor 555 donkey anti-mouse (1/500, Invitrogen,
A31570) for 1 hr 30 min at room temperature. Rabbit anti-GFP (1/500, Invitro-
gen, A11122) and Alexa fluor 488 donkey anti-rabbit (1/500, Invitrogen,
A21206) were used the same way to reveal eNpHR expression in transgenic
mice.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.09.034.
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